Side-by-side comparison of AI visibility scores, market position, and capabilities
Dublin automotive technology (NYSE: APTV) ~$15B revenue; Gen 6 ADAS AI hands-free driving, 800V EV electrical architecture, software-defined vehicle platform for OTA updates competing with Lear and Mobileye.
Aptiv PLC is a Dublin, Ireland-headquartered (operational headquarters in Troy, Michigan) automotive technology company — publicly traded on the New York Stock Exchange (NYSE: APTV) as an S&P 500 Consumer Discretionary component — providing automotive high-voltage electrical architecture systems, advanced driver assistance systems (ADAS), software-defined vehicle platforms, and vehicle connectivity solutions to global automotive original equipment manufacturers through approximately 160,000 employees in 45 countries. Aptiv was spun off from Delphi Automotive in 2017 as the technology-focused entity (retaining signal and power distribution, ADAS, and connectivity businesses) while Delphi Technologies (powertrain components, subsequently acquired by BorgWarner) was separated. At CES 2025, Aptiv showcased its Gen 6 ADAS Platform — featuring AI/ML-powered hands-free driving capable of handling 95%+ of highway driving scenarios — alongside 360-degree perception systems combining bird's-eye-view cameras with ultrashort-range radar, and advanced power distribution architectures designed for software-defined vehicles and high-voltage electric vehicle platforms. CEO Kevin Clark leads Aptiv's strategy of expanding from traditional wiring harnesses and junction boxes toward software-defined vehicle architecture — the migration of automotive electronics from domain-specific ECUs (electronic control units) to centralized compute platforms where software can be updated over-the-air — a fundamental vehicle architecture change that positions Aptiv as the electrical nervous system supplier for next-generation vehicles.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.